These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 31096947)
1. The impact of immunosuppression on postoperative graft function after graft-unrelated surgery: a retrospective controlled cohort study. Lederer AK; Haffa D; Felgendreff P; Makowiec F; Fichtner-Feigl S; Huber R; Kousoulas L BMC Nephrol; 2019 May; 20(1):170. PubMed ID: 31096947 [TBL] [Abstract][Full Text] [Related]
2. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. Favi E; Spagnoletti G; Salerno MP; Pedroso JA; Romagnoli J; Citterio F Clin Transplant; 2013; 27(4):E359-67. PubMed ID: 23710603 [TBL] [Abstract][Full Text] [Related]
3. Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results. Chamienia A; Dębska-Ślizień A; Król E; Biedunkiewicz B; Rutkowski B Transplant Proc; 2014 Oct; 46(8):2714-8. PubMed ID: 25380901 [TBL] [Abstract][Full Text] [Related]
6. Late evolution of kidney transplants in elderly donors and recipients receiving initial immunosuppressant treatment with daclizumab, mycophenolate mofetil, and delayed introduction of tacrolimus. González-Roncero FM; Gentil-Govantes MÁ; González-Molina M; Rivero M; Cantarell C; Alarcón A; Franco A; Sánchez-Plumed J; Lampreabe I; Lauzurica R; González E; Romero R; Ruiz-San Millán JC; Osuna A Nefrologia; 2012 Jul; 32(4):446-54. PubMed ID: 22806279 [TBL] [Abstract][Full Text] [Related]
7. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil. Herrero JI; Quiroga J; Sangro B; Girala M; Gómez-Manero N; Pardo F; Alvárez-Cienfuegos J; Prieto J Liver Transpl Surg; 1999 Sep; 5(5):414-20. PubMed ID: 10477843 [TBL] [Abstract][Full Text] [Related]
8. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection. Boratyńska M; Banasik M; Patrzałek D; Klinger M Ann Transplant; 2006; 11(2):51-6. PubMed ID: 17494290 [TBL] [Abstract][Full Text] [Related]
9. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960 [TBL] [Abstract][Full Text] [Related]
10. Long-term graft outcome in patients with chronic allograft dysfunction after immunosuppression modifications. El-Agroudy AE; El-Dahshan K; Mahmoud K; El-Baz M; Shokeir AA; Ghoneim MA Ann Transplant; 2008; 13(4):46-54. PubMed ID: 19034223 [TBL] [Abstract][Full Text] [Related]
11. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients. Asberg A; Midtvedt K; Line PD; Narverud J; Holdaas H; Jenssen T; Reisaeter AV; Johnsen LF; Fauchald P; Hartmann A Transplantation; 2006 Jul; 82(1):62-8. PubMed ID: 16861943 [TBL] [Abstract][Full Text] [Related]
12. Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study. Neu AM; Ho PL; Fine RN; Furth SL; Fivush BA Pediatr Transplant; 2003 Jun; 7(3):217-22. PubMed ID: 12756047 [TBL] [Abstract][Full Text] [Related]
13. Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia. Knight RJ; Graviss EA; Nguyen DT; Kuten SA; Patel SJ; Gaber L; Gaber AO Clin Transplant; 2018 Jun; 32(6):e13265. PubMed ID: 29676018 [TBL] [Abstract][Full Text] [Related]
14. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. Schlitt HJ; Barkmann A; Böker KH; Schmidt HH; Emmanouilidis N; Rosenau J; Bahr MJ; Tusch G; Manns MP; Nashan B; Klempnauer J Lancet; 2001 Feb; 357(9256):587-91. PubMed ID: 11558484 [TBL] [Abstract][Full Text] [Related]